Orange Book product · Brand (NDA)

BEQALZI

SONROTOCLAX

Brand (NDA)NDA 220711RX BEONE MEDICINES USA

May 13, 2026

Approved

Brand (NDA)

Application

Not listed

TE code

Listed patents

Approval
FDA approval date of this drug product.
May 13, 2026
1 mo ago
Today
Patent 11420968 expires
Listed drug substance patent expiration.
Apr 29, 2039
in 13 yr 1 mo

Active ingredient

SONROTOCLAX

Strength

1MG

Dosage form

TABLET

Route

ORAL

TE code

Not listed

Application

NDA 220711

Product number

001

Marketing status

Reference listed drug (RLD)

Yes

Reference standard (RS)

Active-ingredient family

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
Patent	Expires	In	Type
11420968	Apr 29, 2039	in 13 yr 1 mo	SubstanceProduct